News & Updates

Show Multimedia Only

Which anti-obesity drug is safest, most effective?

27 Jul 2026 by

Among available drugs for obesity, tirzepatide and cagrilintide-semaglutide (CagriSema) yield the largest decrease in body weight, regardless of diabetes status, suggest the results of a systematic review and network meta-analysis.

Which anti-obesity drug is safest, most effective?

27 Jul 2026

Prolonged short sleep may lead to weight gain

24 Jul 2026

Individuals who always have insufficient sleep tend to gain weight, according to a pooled analysis of randomized crossover trials (RCTs).

Prolonged short sleep may lead to weight gain

24 Jul 2026

Survodutide promotes weight loss in adults with obesity

24 Jul 2026

In patients with obesity but without diabetes, treatment with survodutide results in substantial reductions in body weight compared with placebo, according to the phase III SYNCHRONIZE-1 trial.

Survodutide promotes weight loss in adults with obesity

24 Jul 2026

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

23 Jul 2026

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in an increased risk for ischaemic optic neuropathy (ION) at 18 months when compared with the use of sodium‒glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is), reports a study.

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

23 Jul 2026

Older age, obesity, T2D linked to hypertension-mediated organ damage

22 Jul 2026

Factors including older age, obesity, and type 2 diabetes (T2D) characterize individuals with subclinical hypertension-mediated organ damage (HMOD) in The Maastricht Study.

Older age, obesity, T2D linked to hypertension-mediated organ damage

22 Jul 2026

Steroid safety made simple with the new MOH Steroid Card

22 Jul 2026 by

A standardised steroid card is now available after years of effort by a team of endocrinologists and pharmacists from the Ministry of Health (MOH).

Steroid safety made simple with the new MOH Steroid Card

22 Jul 2026

Older age, overweight raise risk of symptomatic VTE in DFF patients

16 Jul 2026 by

A Singapore study has observed a high prevalence of symptomatic venous thromboembolism (VTE) in patients who underwent distal femur fracture (DFF) surgery. Those with advanced age or who are overweight are more likely to develop symptomatic VTE.

Older age, overweight raise risk of symptomatic VTE in DFF patients

16 Jul 2026

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

15 Jul 2026

Administering a single dose of dextrose gel as prophylaxis against transitional neonatal hypoglycaemia does not help with the risk of neurocognitive impairment at early school age and even appears to have adverse effects on psychological well-being, according to a study.

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

15 Jul 2026

Patients with MASLD face heightened diabetes risk

14 Jul 2026 by

Metabolic dysfunction-associated steatotic liver disease (MASLD) carries an increased risk of type 2 diabetes (T2D), with the risk increase disproportionately higher for individuals with earlier-onset MASLD, as shown in a study.

Patients with MASLD face heightened diabetes risk

14 Jul 2026

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

Treatment with the combination of cagrilintide plus semaglutide is safe and efficacious for lowering glycaemic levels in individuals with early-stage type 2 diabetes inadequately controlled with diet and exercise, as shown in the phase IIIa REIMAGINE 1 trial.

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

14 Jul 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Which anti-obesity drug is safest, most effective?

Which anti-obesity drug is safest, most effective?

Prolonged short sleep may lead to weight gain

Prolonged short sleep may lead to weight gain

Survodutide promotes weight loss in adults with obesity

Survodutide promotes weight loss in adults with obesity

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

Older age, obesity, T2D linked to hypertension-mediated organ damage

Older age, obesity, T2D linked to hypertension-mediated organ damage

Steroid safety made simple with the new MOH Steroid Card

Steroid safety made simple with the new MOH Steroid Card

Older age, overweight raise risk of symptomatic VTE in DFF patients

Older age, overweight raise risk of symptomatic VTE in DFF patients

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

Patients with MASLD face heightened diabetes risk

Patients with MASLD face heightened diabetes risk

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes